Brief: Xintela Granted SEK 2 Mln From Vinnova
27/03/2020 10:48
March 27 (Reuters) - Xintela AB XINT.ST :
* XINTELA GRANTED 2 MILLION SEK FROM VINNOVA
* HAS NOW APPLIED FOR AND BEEN GRANTED CO-FINANCING FROM
VINNOVA
TO PRECLINICALLY EVALUATE VARIOUS ADCS TO IDENTIFY AN OPTIMAL
ADC-CANDIDATE FOR TREATMENT OF BRAIN TUMOR GLIOBLASTOMA AND
OTHER AGGRESSIVE CANCERS
Source text for Eikon: ID:nBQN5cyXQV
Further company coverage: XINT.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Xintela AB
See all newsBrief: Xintela To Raise SEK 30 Mln Via Convertible Loan From Flerie Invest
Advisory: Alerts on Xintela's phase I/IIa XSTEM results withdrawn
Brief: Xintela Q1 2026 Loss Before Tax SEK 11.8 Mln
Brief: Xintela Study Finds XSTEM Treatment Safe, Well Tolerated
Brief: Xintela Gets U.S. Patent For Xstem Treatment Of Difficult-To-Heal Wounds, Skin Defects